Gastric & Breast Cancer e-journal
DOI: 10.2122/gbc.2012.0207
NEWS & VIEWS
|
Monitoring EGFR plasma levels: Is it a biomarker for colorectal cancer?
|
|
Affiliation: Eugenia Halkia,
Department of Gynaecology, "METAXA" Cancer Memorial Hospital, Botosi 51, TK 18535, Piraeus, Greece.
E-mail: drhalkia@yahoo.com |
Since there is no abstract available we provide the first paragraph.
Although the EGFR signaling pathways regulates crucial cellular processes including cell proliferation, survival, differentiation, and apoptosis, no evidence exists that EGFR measurement in blood of cancer patients could be used as biomarker for monitoring and predicting of the oncological outcomes of colorectal cancer patients.
(Citation: Gastric & Breast Cancer 2012; 11(1) 32-34).
|
|
| You can have an online full-text access and a PDF of this article: |
- Either purchase this paper for €35 EUR. Please, click here
|
|
- Or through one year subscription PayPal
|
|
Online
ISSN : 1109 - 7647
Print ISSN : 1109 - 7655
 We
subscribe to the HONcode principles. Verify
here.
please, read our policy about privacy
and confidentiality of information and transparency
of sponsorship
last
update: 2 January 2012 |
|
